The Cell Reprogramming Market is on the precipice of a profound transformation, driven by relentless innovation and a burgeoning demand for advanced cellular therapies. This dynamic sector, currently valued at over $400 million, is poised for substantial expansion, with an anticipated Compound Annual Growth Rate (CAGR) of approximately 8.6%. This growth trajectory is fueled by...